microdosing of tirzepatide GLP-1 is popular, but there's little evidence it works Tirzepatide Microdosing: Keep Weight Off?

Amgens MariTide shows approximately 20 percent weight loss in Phase 2 with durable metabolic improvements, signaling a shift toward monthly or lower frequency dosing models

In some cases, surgery might be required to address specific concerns

GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion while suppressing inappropriate glucagon release

Mental Health Considerations Significant changes to your healthcare routine, especially discontinuing a beneficial medication, can have psychological effects

Like any prescribed medication, its essential that you work closely with your provider to ensure your body is responding as expected and your results are ideal